2-oxothiazolidine-4-carboxylic acid has been researched along with Muscular Dystrophy, Duchenne in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, PG; Boyatzis, A; Grounds, MD; Terrill, JR | 1 |
| Arthur, PG; Graves, JA; Grounds, MD; Pinniger, GJ; Terrill, JR | 1 |
2 other study(ies) available for 2-oxothiazolidine-4-carboxylic acid and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Muscular Dystrophy, Duchenne; Oxidative Stress; Pyrrolidonecarboxylic Acid; Taurine; Thiazolidines | 2013 |
Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Topics: Animals; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Pyrrolidonecarboxylic Acid; Taurine; Thiazolidines | 2016 |